Alembic Pharmaceuticals per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹35.27₹34.33₹29.68₹31.33₹17.40
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹35.27₹34.33₹29.68₹31.33₹17.40
₹288.72₹288.72₹264.10₹245.12₹222.34
₹396.03₹373.69₹339.46₹316.87₹287.57
—₹39.82₹4.48₹40.86₹36.83
₹17.71₹17.71−₹24.20₹24.20₹14.27
—₹11.00₹11.00₹8.00₹10.00
19.719.719.719.719.7
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

APLLTD₹794.85

Alembic Pharmaceuticals Ltd.

· Pharma & Health
₹ CrorePeersAJANTPHARMIPCALABTORNTPHARMALIVUSAKUMSAGARWALEYEADVENZYMESAARTIPHARMMcap ₹15,623 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS17.4031.3329.6834.3335.27
Diluted EPS17.4031.3329.6834.3335.27
Book Value per Share222.34245.12264.10288.72288.72
Revenue per Share287.57316.87339.46373.69396.03
Cash Flow per Share36.8340.864.4839.82—
Free Cash Flow per Share14.2724.20-24.2017.7117.71
Dividends per Share10.008.0011.0011.00—
Shares Outstanding (cr)19.719.719.719.719.7
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.